Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Emory scientists find marker for long-term immunity

21.11.2003


Scientists at the Emory Vaccine Center and The Scripps Research Institute have found a way to identify which of the T cells generated after a viral infection can persist and confer protective immunity. Because these long-lived cells protect against reinfection by "remembering" the prior pathogen, they are called memory T cells. This discovery about the specific mechanisms of long-term immunity could help scientists develop more effective vaccines against challenging infections.



The research, by Susan M. Kaech, PhD, a postdoctoral fellow in microbiology and immunology at Emory University School of Medicine, and principal investigator Rafi Ahmed, PhD, director of the Emory Vaccine Center and a Georgia Research Eminent Scholar, was published online November 16 and will be printed in the December issue of Nature Immunology. Other members of the research team were E. John Wherry and Bogumila T. Konieczny of Emory University School of Medicine, and Joyce T. Tan and Charles D. Surh of The Scripps Research Institute.

During an acute viral infection, CD4 and CD8 T cells activated by specific viral antigens dramatically expand in number and become effector T cells. These cells kill the virus-infected cells and also produce cytokines. Most effector cells die within a few weeks, after their initial job is complete. Only about 5 to 10 percent survive to become long-term memory cells, which are capable of mounting a strong and rapid immune response when they come into contact with the original virus, even years later. Scientists have not clearly understood the mechanisms of memory cell production, and a major unanswered question has been how to distinguish the small fraction of cells likely to survive in long-term memory.


This team of investigators found that expression of the interleukin 7 (IL-7) receptor, which binds the cytokine IL-7 and is required for T cell survival, is increased in a small subset of CD8 T cells generated during an acute infection, and that expression of this receptor marks those that will survive to become long-lived memory CD8 T cells.

In experiments with mice, the Emory scientists found that at the peak of the CD8 T cell immune response during an acute viral infection a small subset of effector cells had a higher expression of the IL-7 receptor, and they hypothesized that these cells would be the ones to survive as memory cells. They transferred a group of cells with and without this distinguishing characteristic into mice that were unexposed to virus, and found that in fact the cells expressing IL-7 receptor survived and differentiated into long-lived memory cells. They also found that IL-7 signals were necessary for the survival of these cells.

"We can consider the IL-7 receptor a marker of ’cellular fitness’ for long-term survival and functionality," says Dr. Kaech. "This new knowledge should help us in assessing and predicting the number and quality of memory T cells that will be generated after infection or immunization. It also could lead to the identification of additional markers of memory cells and provide a more comprehensive picture of memory cell development."

"As scientists struggle to create long-term, effective vaccines for difficult diseases, they need a detailed understanding of the mechanisms of long-term memory," says Dr. Ahmed. "Understanding immune memory is the necessary basis for developing any type of effective vaccine. In addition, these findings could help in designing immunotherapies to control chronic viral infections and cancer."

Holly Korschun | EurekAlert!
Further information:
http://www.emory.edu/

More articles from Life Sciences:

nachricht Superresolution live-cell imaging provides unexpected insights into the dynamic structure of mitochondria
18.02.2020 | Heinrich-Heine-Universität Düsseldorf

nachricht Blood and sweat: Wearable medical sensors will get major sensitivity boost
18.02.2020 | Moscow Institute of Physics and Technology

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Freiburg researcher investigate the origins of surface texture

Most natural and artificial surfaces are rough: metals and even glasses that appear smooth to the naked eye can look like jagged mountain ranges under the microscope. There is currently no uniform theory about the origin of this roughness despite it being observed on all scales, from the atomic to the tectonic. Scientists suspect that the rough surface is formed by irreversible plastic deformation that occurs in many processes of mechanical machining of components such as milling.

Prof. Dr. Lars Pastewka from the Simulation group at the Department of Microsystems Engineering at the University of Freiburg and his team have simulated such...

Im Focus: Skyrmions like it hot: Spin structures are controllable even at high temperatures

Investigation of the temperature dependence of the skyrmion Hall effect reveals further insights into possible new data storage devices

The joint research project of Johannes Gutenberg University Mainz (JGU) and the Massachusetts Institute of Technology (MIT) that had previously demonstrated...

Im Focus: Making the internet more energy efficient through systemic optimization

Researchers at Chalmers University of Technology, Sweden, recently completed a 5-year research project looking at how to make fibre optic communications systems more energy efficient. Among their proposals are smart, error-correcting data chip circuits, which they refined to be 10 times less energy consumptive. The project has yielded several scientific articles, in publications including Nature Communications.

Streaming films and music, scrolling through social media, and using cloud-based storage services are everyday activities now.

Im Focus: New synthesis methods enhance 3D chemical space for drug discovery

After helping develop a new approach for organic synthesis -- carbon-hydrogen functionalization -- scientists at Emory University are now showing how this approach may apply to drug discovery. Nature Catalysis published their most recent work -- a streamlined process for making a three-dimensional scaffold of keen interest to the pharmaceutical industry.

"Our tools open up whole new chemical space for potential drug targets," says Huw Davies, Emory professor of organic chemistry and senior author of the paper.

Im Focus: Quantum fluctuations sustain the record superconductor

Superconductivity approaching room temperature may be possible in hydrogen-rich compounds at much lower pressures than previously expected

Reaching room-temperature superconductivity is one of the biggest dreams in physics. Its discovery would bring a technological revolution by providing...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

70th Lindau Nobel Laureate Meeting: Around 70 Laureates set to meet with young scientists from approx. 100 countries

12.02.2020 | Event News

11th Advanced Battery Power Conference, March 24-25, 2020 in Münster/Germany

16.01.2020 | Event News

Laser Colloquium Hydrogen LKH2: fast and reliable fuel cell manufacturing

15.01.2020 | Event News

 
Latest News

Movement of a liquid droplet generates over 5 volts of electricity

18.02.2020 | Power and Electrical Engineering

Powering the future: Smallest all-digital circuit opens doors to 5 nm next-gen semiconductor

18.02.2020 | Information Technology

Studying electrons, bridging two realms of physics: connecting solids and soft matter

18.02.2020 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>